Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse

Marine Cacheux, Jérémy Fauconnier, Jérôme Thireau, Alexis Osseni, Jacques Brocard, Nathalie Roux-Buisson, Julie Brocard, Julien Fauré, Alain Lacampagne, Isabelle Marty

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is induced by mutations in triadin or calsequestrin. Deletion/mutation of triadin is associated with reduction in calsequestrin and leads to CPVT. Cacheux and colleagues show that partial re-expression of triadin and calsequestrin through gene or pharmacological therapy reverses this cardiac arrhythmia.

Original languageEnglish
Pages (from-to)171-179
Number of pages9
JournalMolecular Therapy
Volume28
Issue number1
DOIs
StatePublished - 8 Jan 2020
Externally publishedYes

Keywords

  • Ca release
  • cardiac arrhythmia
  • gene therapy
  • genetic disease
  • sarcoplasmic reticulum

Fingerprint

Dive into the research topics of 'Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse'. Together they form a unique fingerprint.

Cite this